Cargando…

Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro

BACKGROUND: Polybrominated diphenyl ethers (PBDEs) are flame-retardant chemicals that accumulate in human tissues and are potential toxicants. Concentrations of PBDEs in human tissues have increased recently, and body burdens in the U.S. and Canadian populations are higher than in any other region....

Descripción completa

Detalles Bibliográficos
Autores principales: Stapleton, Heather M., Kelly, Shannon M., Pei, Ruoting, Letcher, Robert J., Gunsch, Claudia
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649220/
https://www.ncbi.nlm.nih.gov/pubmed/19270788
http://dx.doi.org/10.1289/ehp.11807
_version_ 1782165036465127424
author Stapleton, Heather M.
Kelly, Shannon M.
Pei, Ruoting
Letcher, Robert J.
Gunsch, Claudia
author_facet Stapleton, Heather M.
Kelly, Shannon M.
Pei, Ruoting
Letcher, Robert J.
Gunsch, Claudia
author_sort Stapleton, Heather M.
collection PubMed
description BACKGROUND: Polybrominated diphenyl ethers (PBDEs) are flame-retardant chemicals that accumulate in human tissues and are potential toxicants. Concentrations of PBDEs in human tissues have increased recently, and body burdens in the U.S. and Canadian populations are higher than in any other region. OBJECTIVES: Although metabolism in animal laboratory studies has been examined, no studies have explored the metabolism of these contaminants in human tissues. We undertook this study to determine whether PBDEs could be metabolized by human liver cells in vitro and to identify what types of metabolites are formed. METHODS: We exposed hepatocytes from three different donors (two cryopreserved batches and one fresh batch) to solutions containing 10 μM of either of two environmentally relevant and prominent PBDE congeners—BDE-99 or BDE-209—for periods of 24–72 hr. We also conducted gene expression analysis to provide information on potential induction of xenobiotic metabolizing enzymes. RESULTS: Exposing hepatocytes to BDE-99 resulted in the formation of 2,4,5-tribromo phenol, two monohydroxylated pentabrominated diphenyl ether metabolites, and a yet unidentified tetrabrominated metabolite. No hydroxylated or debrominated metabolites were observed in the cells exposed to BDE-209. This suggests that BDE-209 was not metabolized, that nonextractable, covalently protein-bound metabolites were formed, or that the exposure time was not long enough for BDE-209 to diffuse into the cell to be metabolized. However, we observed up-regulation of genes encoding for cytochrome P450 monooxygenase (CYP) 1A2, CYP3A4, deiodinase type 1, and glutathione S-transferase M1 in hepatocyes exposed to both BDE-99 and BDE-209. CONCLUSIONS: Our in vitro results suggest that the human liver will likely metabolize some BDE congeners (e.g., BDE-99) in vivo. These metabolites have been shown to elicit greater toxicity than the parent BDE congeners in laboratory bioassays; thus, more research on body burdens and human health effects from these metabolites are warranted.
format Text
id pubmed-2649220
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-26492202009-03-06 Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro Stapleton, Heather M. Kelly, Shannon M. Pei, Ruoting Letcher, Robert J. Gunsch, Claudia Environ Health Perspect Research BACKGROUND: Polybrominated diphenyl ethers (PBDEs) are flame-retardant chemicals that accumulate in human tissues and are potential toxicants. Concentrations of PBDEs in human tissues have increased recently, and body burdens in the U.S. and Canadian populations are higher than in any other region. OBJECTIVES: Although metabolism in animal laboratory studies has been examined, no studies have explored the metabolism of these contaminants in human tissues. We undertook this study to determine whether PBDEs could be metabolized by human liver cells in vitro and to identify what types of metabolites are formed. METHODS: We exposed hepatocytes from three different donors (two cryopreserved batches and one fresh batch) to solutions containing 10 μM of either of two environmentally relevant and prominent PBDE congeners—BDE-99 or BDE-209—for periods of 24–72 hr. We also conducted gene expression analysis to provide information on potential induction of xenobiotic metabolizing enzymes. RESULTS: Exposing hepatocytes to BDE-99 resulted in the formation of 2,4,5-tribromo phenol, two monohydroxylated pentabrominated diphenyl ether metabolites, and a yet unidentified tetrabrominated metabolite. No hydroxylated or debrominated metabolites were observed in the cells exposed to BDE-209. This suggests that BDE-209 was not metabolized, that nonextractable, covalently protein-bound metabolites were formed, or that the exposure time was not long enough for BDE-209 to diffuse into the cell to be metabolized. However, we observed up-regulation of genes encoding for cytochrome P450 monooxygenase (CYP) 1A2, CYP3A4, deiodinase type 1, and glutathione S-transferase M1 in hepatocyes exposed to both BDE-99 and BDE-209. CONCLUSIONS: Our in vitro results suggest that the human liver will likely metabolize some BDE congeners (e.g., BDE-99) in vivo. These metabolites have been shown to elicit greater toxicity than the parent BDE congeners in laboratory bioassays; thus, more research on body burdens and human health effects from these metabolites are warranted. National Institute of Environmental Health Sciences 2009-02 2008-09-02 /pmc/articles/PMC2649220/ /pubmed/19270788 http://dx.doi.org/10.1289/ehp.11807 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Stapleton, Heather M.
Kelly, Shannon M.
Pei, Ruoting
Letcher, Robert J.
Gunsch, Claudia
Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro
title Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro
title_full Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro
title_fullStr Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro
title_full_unstemmed Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro
title_short Metabolism of Polybrominated Diphenyl Ethers (PBDEs) by Human Hepatocytes in Vitro
title_sort metabolism of polybrominated diphenyl ethers (pbdes) by human hepatocytes in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649220/
https://www.ncbi.nlm.nih.gov/pubmed/19270788
http://dx.doi.org/10.1289/ehp.11807
work_keys_str_mv AT stapletonheatherm metabolismofpolybrominateddiphenyletherspbdesbyhumanhepatocytesinvitro
AT kellyshannonm metabolismofpolybrominateddiphenyletherspbdesbyhumanhepatocytesinvitro
AT peiruoting metabolismofpolybrominateddiphenyletherspbdesbyhumanhepatocytesinvitro
AT letcherrobertj metabolismofpolybrominateddiphenyletherspbdesbyhumanhepatocytesinvitro
AT gunschclaudia metabolismofpolybrominateddiphenyletherspbdesbyhumanhepatocytesinvitro